Molecular Characterization of the Carboxypeptidase B1 of Anopheles stephensi and Its Evaluation as a Target for Transmission-Blocking Vaccines
ABSTRACTMalaria is one of the most important infectious diseases in the world, and it has many economic and social impacts on populations, especially in poor countries. Transmission-blocking vaccines (TBVs) are valuable tools for malaria eradication. A study onAnopheles gambiaerevealed that polyclonal antibodies to carboxypeptidase B1 ofA. gambiaecan block sexual parasite development in the mosquito midgut. Hence, it was introduced as a TBV target in regions whereA. gambiaeis the main malaria vector. However, in Iran and neighboring countries as far as China, the main malaria vector isAnopheles stephensi. Also, the genome of this organism has not been sequenced yet. Therefore, in this study, carboxypeptidase B1 ofA. stephensiwas characterized by genomic and proteomic approaches. Furthermore, its expression pattern after ingestion ofPlasmodium falciparumgametocytes and the effect of anti-CPBAs1 antibodies on sexual parasite development were evaluated. Our results revealed that thecpbAs1expression level was increased after ingestion of the mature gametocytes ofP. falciparumand that anti-CPBAs1 directed antibodies could significantly reduce the mosquito infection rate in the test group compared with the control group. Therefore, according to our findings and with respect to the high similarity of carboxypeptidase enzymes between the two main malaria vectors in Africa (A. gambiae) and Asia (A. stephensi) and the presence of other sympatric vectors, CPBAs1 could be introduced as a TBV candidate in regions whereA. stephensiis the main malaria vector, and this will broaden the scope for the potential wider application of CPBAs1 antigen homologs/orthologs.